1. Home
  2. TRNR vs VTAK Comparison

TRNR vs VTAK Comparison

Compare TRNR & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRNR

Interactive Strength Inc.

N/A

Current Price

$1.46

Market Cap

2.5M

Sector

Technology

ML Signal

N/A

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

N/A

Current Price

$1.38

Market Cap

2.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRNR
VTAK
Founded
2017
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
2.9M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
TRNR
VTAK
Price
$1.46
$1.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.3M
67.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
89.53
EPS
N/A
N/A
Revenue
$5,380,000.00
$442,000.00
Revenue This Year
$245.67
$822.86
Revenue Next Year
$119.39
$168.42
P/E Ratio
N/A
N/A
Revenue Growth
459.25
3057.14
52 Week Low
$0.19
$0.15
52 Week High
$8.20
$4.31

Technical Indicators

Market Signals
Indicator
TRNR
VTAK
Relative Strength Index (RSI) 57.29 36.30
Support Level $0.81 $1.14
Resistance Level $1.62 $2.05
Average True Range (ATR) 0.19 0.10
MACD 0.06 -0.01
Stochastic Oscillator 56.21 11.11

Price Performance

Historical Comparison
TRNR
VTAK

About TRNR Interactive Strength Inc.

Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue and personal training revenue.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: